Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 885.00
-8.05 (-0.90%)
Sep 11, 2026, 3:14 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 10.26 billion as of September 11, 2026. Its market cap has increased by 4.31% in one year.
Market Cap
10.26B
Enterprise Value
10.35B
Revenue
8.54B
Ranking
n/a
PE Ratio
22.45
Stock Price
885.00
ChartMarket Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 10.26B, an increase of 287.62%. That is a compound annual growth rate of 50.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.26B | 25.32% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 16.65B |
| Infinium Pharmachem | 4.41B |
| Quest Laboratories | 1.43B |
| Sotac Pharmaceuticals | 995.05M |
| Zenith Drugs | 824.86M |
| Vilin Bio Med | 807.01M |
| Medicamen Organics | 294.84M |
| Sunrest Lifescience | 169.29M |